Fukuda Denshi CoTSE:6960 +1.78%81 Net Margin % is 12.18% as of Dec. 2025, which is 9% above its 10-year median of 11.16. GuruFocus rates TSE:6960 with a GF Score™ of 81/100 and a GF Value™ of 円7,323.71 (Significantly Overvalued). Among 817 Medical Devices & Instruments companies, Fukuda Denshi Co ranks better than 80.29% on this metric.
The historical rank and industry rank for Fukuda Denshi Co's Net Margin % or its related term are showing as below:
TSE:6960'
s Net Margin % Range Over the Past 10 Years
Min: 7.2 Med: 11.16 Max: 13.45
Current: 13.45
TSE:6960's Net Margin % is ranked better than 80.29% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs TSE:6960: 13.45
Fukuda Denshi Co (TSE:6960) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Fukuda Denshi Co Net Margin % Related Terms
Fukuda Denshi Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6960 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Fukuda Denshi Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fukuda Denshi Co (TSE:6960) has a Net Margin % of 12.18% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Fukuda Denshi Co and its competitors. This is near median its historical median of 11.16. Over the past decade, Fukuda Denshi Co's Net Margin % has ranged from 7.20 to 13.45. According to the industry distribution chart, Fukuda Denshi Co ranks #161 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 19.7%.
Is Fukuda Denshi Co's Net Margin % too high?
Fukuda Denshi Co's current Net Margin % of 12.18% is near median its 10-year median of 11.16. Over the past 10 years, this metric has ranged from a low of 7.20 to a high of 13.45. The Medical Devices & Instruments industry median Net Margin % is 2.09. Fukuda Denshi Co's value of 12.18% is 482.8% above this industry median. Based on the distribution chart, Fukuda Denshi Co ranks #161 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fukuda Denshi Co has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #161 out of 817 companies for Net Margin %. This places Fukuda Denshi Co in the top 20% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.09. Fukuda Denshi Co's value of 12.18% is 482.8% above this benchmark. Historically, Fukuda Denshi Co's own Net Margin % has ranged from 7.20 to 13.45 over the past decade. While the company's 10-year median is 11.16 vs. the industry median of 2.09, Fukuda Denshi Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current Net Margin % of 12.18% is 482.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current Net Margin % is 12.18%, which is near median its own 10-year median of 11.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Based on GuruFocus' analysis, Fukuda Denshi Co (TSE:6960) is currently considered Significantly Overvalued. The stock's GF Value™ is 円7,323.71, compared to a current price of 円10,860.00 — trading 48.3% above its estimated fair value. The current Net Margin % is 12.18%, which is near median its 10-year median of 11.16 and 482.8% above the Medical Devices & Instruments industry median of 2.09. Fukuda Denshi Co's overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Fukuda Denshi Co (TSE:6960), the current Net Margin % is 12.18% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (TSE:6960) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of 円10,860.00 is trading 48.3% above its estimated GF Value™ of 円7,323.71.
GuruFocus considers Fukuda Denshi Co to be Significantly Overvalued.
Key valuation signals for TSE:6960:
Net Margin %: 12.18% (near median its 10-year median of 11.16)
GF Value™: 円7,323.71 vs. price of 円10,860.00 (48.3% above fair value)
Industry Position: 482.8% above the Medical Devices & Instruments median (#161 of 817)
No single metric tells the full story. See the TSE:6960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
81GF Score
Get the complete analysis for TSE:6960
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6960 has been successfully added to your 
